Evolution of drug resistance in Mycobacterium tuberculosis:: Clinical and molecular perspective

被引：288

作者：

Gillespie, SH ^{[1
]}

机构：

[1] UCL, Royal Free & Univ Coll Med Sch, London NW3 2PF, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 02期

关键词：

D O I：

10.1128/AAC.46.2.267-274.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：267 / 274

页数：8

共 86 条

[21] Mutant prevention concentration as a measure of antibiotic potency:: Studies with clinical isolates of Mycobacterium tuberculosis [J].

Dong, YZ ;

Zhao, XL ;

Kreiswirth, BN ;

Drlica, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2581-2584

[22]

Dormandy Thomas, 1999, The White Death: A History of Tuberculosis

[23]

DOSTER B, 1973, AM REV RESPIR DIS, V107, P177

[24] The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes [J].

Drake, JW .

MOLECULAR STRATEGIES IN BIOLOGICAL EVOLUTION, 1999, 870 :100-107

[25] DNA gyrase, topoisomerase IV, and the 4-quinolones [J].

Drlica, K ;

Zhao, XL .

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+

[26]

Dye C, 2000, INT J TUBERC LUNG D, V4, pS146

[27]

DYE C, 2000, P ROY SOC LOND B BIO, V267, P1

[28]

EAST AFRICAN/BRITISH MEDICAL RESEARCH COUNCILS STUDY, 1981, American Review of Respiratory Disease, V123, P165

[29] AN OUTBREAK OF MULTIDRUG-RESISTANT TUBERCULOSIS AMONG HOSPITALIZED-PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

EDLIN, BR ;

TOKARS, JI ;

GRIECO, MH ;

CRAWFORD, JT ;

WILLIAMS, J ;

SORDILLO, EM ;

ONG, KR ;

KILBURN, JO ;

DOOLEY, SW ;

CASTRO, KG ;

JARVIS, WR ;

HOLMBERG, SD .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (23) :1514-1521

[30] FAILURE OF DRUG PENETRATION AND ACQUISITION OF DRUG-RESISTANCE IN CHRONIC TUBERCULOUS EMPYEMA [J].

ELLIOTT, AM ;

BERNING, SE ;

ISEMAN, MD ;

PELOQUIN, CA .

TUBERCLE AND LUNG DISEASE, 1995, 76 (05) :463-467

← 1 2 3 4 5 6 7 8 9 →